Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$463.67 - $597.16 $189,177 - $243,641
-408 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$524.57 - $735.42 $33,572 - $47,066
-64 Reduced 13.56%
408 $230,000
Q4 2021

Feb 08, 2022

BUY
$708.84 - $794.68 $12,759 - $14,304
18 Added 3.96%
472 $357,000
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $5,261 - $6,606
8 Added 1.79%
454 $339,000
Q2 2021

Aug 12, 2021

BUY
$576.64 - $649.04 $2,883 - $3,245
5 Added 1.13%
446 $287,000
Q1 2021

May 14, 2021

SELL
$547.01 - $662.35 $34,461 - $41,728
-63 Reduced 12.5%
441 $252,000
Q4 2020

Feb 09, 2021

BUY
$510.68 - $643.45 $8,170 - $10,295
16 Added 3.28%
504 $294,000
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $59,075 - $69,628
-130 Reduced 21.04%
488 $252,000
Q2 2020

Aug 03, 2020

SELL
$334.87 - $493.06 $129,259 - $190,321
-386 Reduced 38.45%
618 $279,000
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $236,167 - $301,893
-738 Reduced 42.37%
1,004 $352,000
Q4 2019

Feb 18, 2020

SELL
$319.73 - $374.2 $10,231 - $11,974
-32 Reduced 1.8%
1,742 $645,000
Q3 2019

Nov 12, 2019

SELL
$304.55 - $345.24 $119,079 - $134,988
-391 Reduced 18.06%
1,774 $590,000
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $67,428 - $73,458
-235 Reduced 9.79%
2,165 $677,000
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $173,608 - $245,675
774 Added 47.6%
2,400 $734,000
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $219,879 - $308,691
-999 Reduced 38.06%
1,626 $378,000
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $39,052 - $44,030
-135 Reduced 4.89%
2,625 $822,000
Q2 2018

Aug 13, 2018

SELL
$244.1 - $303.88 $22,457 - $27,956
-92 Reduced 3.23%
2,760 $796,000
Q1 2018

May 14, 2018

BUY
$233.97 - $274.11 $89,376 - $104,710
382 Added 15.47%
2,852 $713,000
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $54,018 - $67,553
-249 Reduced 9.16%
2,470 $590,000
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $28,444 - $32,465
134 Added 5.18%
2,719 $604,000
Q2 2017

Aug 11, 2017

BUY
N/A
2,585
2,585 $585,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.